Independent
Tenure on this board
14.1 yrs
Also a director at
United Therapeutics Corp (UTHR)
4 nominees · 5 ballot items.
Five proposals are on the ballot: (1) election of four directors to serve until the next annual meeting; (2) advisory Say-on-Pay regarding the compensation of named executive officers for the fiscal year ended December 31, 2024; (3) advisory Say-on-Frequency regarding the frequency of future Say-on-Pay votes; (4) ratification of Berkowitz Pollack Brant as the independent auditor for the fiscal year ending December 31, 2025; and (5) approval of an amendment to increase the number of authorized shares of common stock to 640,000,000.
Election of four directors to serve until our next annual meeting of stockholders or until their successors are duly elected and qualified.
Advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.
Advisory vote on the frequency of future Say-on-Pay votes.
Ratification of Berkowitz Pollack Brant Advisors + CPAs, LLP as the independent auditor for the fiscal year ending December 31, 2025.
Increase the number of authorized shares of common stock from 32,000,000 to 640,000,000.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Rubric Capital Management LP | 10.3% | 1,192,191 | $2M |
| 2 | Clearline Capital LP | 5.5% | 635,222 | $1M |
| 3 | Squadron Capital Management LLC | 3.6% | 420,421 | $849K |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.1% | 353,697 | $714K |
| 5 | Tejara Capital Ltd | 3.0% | 345,852 | $699K |
| 6 | ADAR1 Capital Management, LLC | 1.8% | 209,210 | $423K |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 1.3% | 146,200 | $295K |
| 8 | MORGAN STANLEY | 1.1% | 128,254 | $259K |
| 9 | BlackRock, Inc. | 1.0% | 114,399 | $231K |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.8% | 95,645 | $193K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.